Abstract Background: As cannabis legalization expands nationally and globally, its use for chronic pain increases, prompting people to seek information…
Abstract Neuropathic pain, a debilitating condition, remains challenging to manage effectively. An insight into neuropharmacological mechanisms is critical for optimizing…
Abstract Changes in chronic noncancer pain treatment have led to decreases in prescribing of opioids and increases in the availability…
Abstract Background: Abuse of non-opioid analgesics (NOA) is associated with serious health consequences. However, due to inconsistent definitions of NOA…
Abstract Enriched enrollment randomized withdrawal (EERW) pain trials are designed to include only responders with considerable pain relief without unacceptable…
Abstract Background: Cannabidiol (CBD) is the non-euphoriant component of cannabis. In 2017, the New Zealand Misuse of Drugs Regulations (1977)…